← AI-Native VC & PE Funds·CASE 001·IMPACTPAUL JUAREZ·case file open
§ 00 ── ANANDA IMPACT VENTURES · ARTICLE 9 · IMPACT CARRY

You publish the impact-carry formula. The mathematics is clean. The evidence chain beneath it scales non-linearly with each new portco — and SFDR 2.0 will force a replay.

48 portcos · 5 vintages · one evidence chain

§ 01 ── THE PATTERN

The formula scales; the evidence beneath each Rx reading does not.

THE FORMULAS YOU PUBLISH
Mc = Σ (Rx / Tx) · wxCompany Impact Multiple
Mp = Σ Mc · (Ic / Ip)Portfolio Impact Multiple
WHAT'S OBSERVABLE

Public: the formulas above, Article 9 status, 48 investments across 5 funds and 15 vintages, €270M AUM, bespoke KPIs per portco.

WHAT'S STRUCTURALLY HAPPENING

Each Rx reading and Tx target gets set, revised, re-weighted, or re-benchmarked as portcos pivot and methodology evolves. The mathematical surface stays clean. The evidence cadence beneath drifts unmeasured.

THE CARRY CLIFF
IMPACT ACHIEVEMENT
CARRY TO TEAM
0 – 59%
0%
60%
10%
70%
15%
80%
20%
WHAT IT COSTS

Carry calculation, LP reporting, and SFDR audit defense rest on Rx readings whose provenance lives in spreadsheets, emails, and founder updates. SFDR 2.0 — no grandfathering — will surface this.

§ 02 ── WHY THIS HAPPENS · STRUCTURALLY

The mathematics is the public layer. The evidence chain is the load-bearing layer.

PARTNER · NATURAL LANGUAGE

Forty-eight portcos. Bespoke KPIs. Five fund vintages. Six senior investors rotating responsibilities. Founders pivot. Methodology evolves. Each Rx reading you booked last year may need to be reread next year against a refined target. The formula stays clean; the readings beneath it accumulate quiet revisions.

SUBSTRATE · TRANSLATED
AUDIT CHAIN
every Rx reading hash-chained, append-only, never-deletable, with evidence mode tagged at emission [verified] [inferred] [model-derived] [stale] [contradictory].
SCHEMA MIGRATION REPLAY
methodology version bumps replay-tested against historical decisions. The formula stays public. What changes is what stands behind each reading.
INSIDE Mp · WHAT Rx ACTUALLY MEANS
PORTCO
Rx UNIT
EVIDENCE REGIME
OroraTech
hectares of forest
satellite telemetry
NatureMetrics
IUCN species
eDNA assays
DrDoctor
patients / month
EHR-side counters
Klim
hectares of farmland
farmer-reported
Quantistry
chemical simulations
platform telemetry

built for SFDR 2.0 replay · before the requalification window opens

§ 03 ── A PHASE 0 PROPOSITION · TWO WEEKS · FREE · ONE PORTCO · ZERO REAL DATA

Pick one portco. We rebuild its Rx evidence chain in synthetic. You see the carry cliff coming or you don't.

Phase 0 is not a pilot. It is a two-week structural diagnostic against one portco of your choice — synthetic data only, your environment or ours, no production access required. The question it answers is narrow and load-bearing: under SFDR 2.0 requalification, does this portco's Rx evidence regime survive replay across two methodology versions, or does it drift into the carry cliff? Three artifacts come out the other side. You keep all three whether you continue or not.

THE DIAGNOSTIC · WHAT TWO WEEKS PRODUCES

  1. 01
    Methodology overlay v0.1

    Your portco's R_x, T_x, and w_x encoded as L2 YAML — the evidence regime made inspectable. One portco. Versioned. Portable. Yours unconditionally — runs in your environment without us.

  2. 02
    Synthetic-data replay

    The audit chain populated against synthetic Rₓ readings across two methodology versions of the same portco — the carry cliff simulated before it costs you a basis point. No real portfolio data. Replay test demonstrated end-to-end. The drift is visible or it isn't.

  3. 03
    Risk-surfaced business case

    Cost model framed against SFDR 2.0 requalification timing, LP audit-defensibility, and carry-tier evidentiary defense — risks named, not minimized. What Phase 1 would cost. What it would not solve. Where this approach breaks.

↓ LIVE · INTERROGATE THE CASE
§ 04 ── THE MOST LOAD-BEARING SECTION

Pressure-test the proposition. Ask where the audit chain breaks.

The substrate answers in its own voice — the same primitive we'd install on your methodology. Not a demo. The actual reasoning surface.

STREAMING · κ ≥ 0.85 · ANONYMITY HOLDS · CITATIONS BY DEFAULT

↵ to send · ⇧↵ for newline
first-principles probes:
§ END ── THE NEXT STEP

If the pattern reads true, the next step is to test whether one portco is the right Phase 0 target.

If relevant, I can send a short async questionnaire — no call needed — and build a no-charge synthetic-data Phase 0 PoC "Ananda AI OS". Within two weeks, replay one AI-native portco's evidence chain against Article 6(1) before the notified bodies start citing it.